Clinical Trial Update: Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma [NA]

View source ↗

Summary

A Phase 2 trial evaluating hypofractionation with proton beam therapy for prostate adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma

Drugs mentioned

• Proton beam therapy (proton beam therapy)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Prostate Adenocarcinoma | NA | Status: COMPLETED